Varicella in Americans from NHANES III: Implications for control through routine immunization

Journal of Medical Virology

Volumn 70, Issue SUPPL. 1, 2003, Pages

  Kilgore, Paul E ^a,b   Kruszon Moran, Deanna ^d   Seward, Jane F ^b   Jumaan, Aisha ^b   Van Loon, Frederik P L ^b,f   Forghani, Bagher ^e   McQuillan, Geraldine M ^d   Wharton, Melinda ^b   Fehrs, Laura J ^c   Cossen, Cynthia K ^e   Hadler, Stephen C ^b  

^a International Vaccine Institute   (South Korea)

^b CENTERS FOR DIS CONTR AND PREV   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL CENTER FOR HEALTH STATISTICS   (United States)

^e VIRAL AND RICKETTSIAL DISEASE LABORATORY   (United States)

^f Centrum De Nieuwe Vaart   (Netherlands)

Author keywords

Chickenpox; Chickenpox vaccine; Health surveys; Herpesvirus 3, human; Immunoenzyme techniques; Immunologic surveillance; Population surveillance; Seroepidemiologic stud ies; Surveillance; United States; Vaccination; Viral vaccines; Virus diseases

Indexed keywords

CHICKENPOX VACCINE; IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; AGED; CHICKENPOX; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ETHNOLOGY; FEMALE; HEALTH SURVEY; HUMAN; IMMUNITY; IMMUNIZATION; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MARRIAGE; POPULATION RESEARCH; SEROPREVALENCE; UNITED STATES; VARICELLA ZOSTER VIRUS; VEIN PUNCTURE;

ADOLESCENT; ADULT; AGED; CHICKENPOX; CHICKENPOX VACCINE; CHILD; ETHNIC GROUPS; FEMALE; HUMANS; IMMUNIZATION; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES;

HERPESVIRIDAE; HUMAN HERPESVIRUS 3;

EID: 0037401940     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10364     Document Type: Conference Paper

References (43)

1. Alter SJ, Hammond JA, McVey CJ, Myers MG. 1986. Susceptibility to varicella-zoster virus among adults at high risk for exposure. Infect Control 7:448-451.
2. American Statistical Association. 1993. Proceedings of the section on survey research methods. Alexandria, VA: ASA.
3. Atkinson WL, Orenstein WA, Krugman S. 1992. The resurgence of measles in the United States, 1989-1990. Annu Rev Med 43:451-463.
4. Collett D. 1991. Binary modeling, 1st ed. London: Chapman and Hall, 1991.
5. Daniel WW. 1999. Analysis of variance. In: Biostatistics: a foundation for analysis in the health sciences, 7th edition. New York: John Wiley and Sons, Inc. p. 314-317.
6. Finger R, Hughes JP, Meade BJ, Pelletier AR, Palmer CT. 1994. Age-specific incidence of chickenpox. Public Health Rep 109:750-755.
7. Forghani B, Schmidt NJ, Dennis J. 1978. Antibody assays for varicellazoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation. J Clin Microbiol 8:545-552.
8. Galil K, Brown C, Lin F, Seward J. 1999. Hospitalizations for varicella in the United States, 1988-1995. Pediatr Infect Dis J. 2002 Oct; 21(10):931-935.
9. Garnett GP, Cox MJ, Bundy DA, Didier JM, St. Catharine J. 1993. The age of infection with varicella-zoster virus in St Lucia, West Indies. Epidemiol Infect 110:361-372.
10. Gershon AA, Raker R, Steinberg S, Topf-Olstein B, Drusin LM. 1976. Antibody to Varicella-Zoster virus in parturient women and their offspring during the first year of life. Pediatrics 58:692-696.
11. Gunter EW, McQuillan G. 1990. Quality control in planning and operating the laboratory component for the Third National Health and Nutrition Examination Survey. J Nutr 120(Suppl 11):1451-1454.
12. Hoekstra EJ, LeBaron CW, Megaloeconomou Y, et al. 1998. Impact of a large-scale immunization initiative in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC). JAMA 280:1143-1147.
13. Jackson LA, Stewart LK, Solomon SL, et al. 1996. Risk of infection with hepatitis A, B or C, cytomegalovirus, varicella or measles among child care providers. Pediatr Infect Dis J 15:584-589.
14. Kelley PW, Petruccelli BP, Stehr-Green P, Erickson RL, Mason CJ. 1991. The susceptibility of young adult Americans to vaccinepreventable infections. A national serosurvey of US Army recruits. JAMA 266:2724-2729.
15. Kuter BJ, Weibel RE, Guess HA, et al. 1991. Oka/Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies. Vaccine 9:643-647.
16. Lantz PM, House JS, Lepkowski JM, Williams DR, Mero RP, Chen J. 1998. Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults. JAMA 279:1703-1708.
17. Lee BW. 1998. Review of varicella zoster seroepidemiology in India and Southeast Asia. Trop Med Int Health 3:886-890.
18. Lieu TA, Cochi SL, Black SB, et al. 1994. Cost-effectiveness of a routine varicella vaccination program for US children [see comments]. JAMA 271:375-381.
19. Longfield JN, Winn RE, Gibson RL, Juchau SV, Hoffman PV. 1990. Varicella outbreaks in Army recruits from Puerto Rico. Varicella susceptibility in a population from the tropics. Arch Intern Med 150:970-973.
20. Maldonado G, Greenland S. 1993. Simulation study of confounderselection strategies. Am J Epidemiol 138:923-936.
21. Mandal BK, Mukherjee PP, Murphy C, Mukherjee R, Naik T. 1998. Adult susceptibility to varicella in the tropics is a rural phenomenon due to the lack of previous exposure. J Infect Dis 178(Suppl 1):S52-S54.
22. McQuillan GM, Gunter EW, Lannom L. 1990. Field issues for the plan and operation of the laboratory component of the Third National Health and Nutrition Examination Survey. J Nutr 120(Suppl 11):1446-1450.
23. Meyer PA, Seward JF, Jumaan AO, Wharton M. 2000. Varicella Mortality: Trends before Vaccine Licensure in the United States, 1970-1994. J Infect Dis 182:383-390.
24. MMWR. 1996a. Recommended childhood immunization schedule: United States, January-June 1996. MMWR Morb Mortal Wkly Rep 44:940-943.
25. MMWR. 1996b. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). 1996. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 45(RR-17):1-36.
26. MMWR. 1997. Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). 1997. MMWR Morb Mortal Wkly Rep 46(RR-18):1-42.
27. MMWR. 1999. Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP). 1999. MMWR Morb Mortal Wkly Rep 48(RR-6):1-5.
28. MMWR. 2000. National, state, and urban area vaccination coverage levels among children aged 19-35 months: United States, 1999. 2000. MMWR Morb Mortal Wkly Rep 49:585-589.
29. Mohadjer L, Montaquila J, Waksberg J. 1996. National Health and Nutrition Examination Survey III: Weighting and Examination Methodology. Hyattsville, MD: Published for the National Center for Health Statistics by Westat, Inc.
30. Muench R, Nassim C, Niku S, Sullivan-Bolyai JZ. 1986. Seroepidemiology of varicella. J Infect Dis 153:153-155.
31. National Center for Health Statistics. 1992. Sample Design: Third National Health and Nutrition Examination Survey, 1988-94. Series 2nd ed. Washington, DC: Government Printing Office.
32. Nieburg D. 1998. Varicella outbreak among initial entry trainees, Fort Know, Kentucky. MSMR Milit Surveill Month Rep 04:16-17.
33. Preblud SR, D'Angelo LJ. 1979. Chickenpox in the United States, 1972-1977. J Infect Dis 140:257-260.
34. Preblud SR, Orenstein WA, Bart KJ. 1984. Varicella: clinical manifestations, epidemiology and health impact in children. Pediatr Infect Dis 3:505-509.
35. Santoli JM, Setia S, Rodewald LE, O'Mara D, Gallo B, Brink E. 2000. Immunization pockets of need: science and practice. Am J Prev Med 19(Suppl 3):89-98.
36. Shah BV, Barnwell BG, Hurt PN, La Vange LM. 1996. SUDAAN Users Manual release 5.50. Cary, NC: Research Triangle Institute.
37. Struewing JP, Hyams KC, Tueller JE, Gray GC. 1993. The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits. Am J Public Health 83:1717-1720.
38. Szilagyi PG, Bordley C, Vann JC, et al. 2000. Effect of patient reminder/recall interventions on immunization rates: a review. JAMA 284:1820-1827.
39. U.S. Preventive Services Task Force. 1996. Guide to clinical preventive services, 2nd ed. Baltimore: Williams & Wilkins.
40. Weber DJ, Rutala WA, Hamilton H. 1996. Prevention and control of varicella-zoster infections in healthcare facilities. Infect Control Hosp Epidemiol 17:694-705.
41. Weibel RE, Neff BJ, Kuter BJ, et al. 1984. Live attenuated varicella virus vaccine. Efficacy trial in healthy children. N Engl J Med 310:1409-1415.
42. Wharton M. 1996. The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am 10:571-581.
43. Yawn BP, Yawn RA, Lydick E. 1997. Community impact of childhood varicella infections. J Pediatr 130:759-765.